Browsing byAuthorAnand, K

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 25 to 29 of 29< previous 
Issue DateTitleAuthor(s)
2022-11-11Recent Trends in rationally designed molecules as kinase inhibitors.Prasher, P; Sharma, M; Chan, Y; Singh, SK; Anand, K; Dureja, H; Jha, NK; Gupta, G; Zacconi, F; Chellappan, DK; Dua, K
2021-06Recent updates on animal models for understanding the etiopathogenesis of polycystic ovarian syndromeCorrie, L; Gulati, M; Singh, SK; Kapoor, B; Khursheed, R; Awasthi, A; Vishwas, S; Chellappan, DK; Gupta, G; Jha, NK; Anand, K; Dua, K
2021-03Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitroPaudel, KR; Wadhwa, R; Tew, XN; Lau, NJX; Madheswaran, T; Panneerselvam, J; Zeeshan, F; Kumar, P; Gupta, G; Anand, K; Singh, SK; Jha, NK; MacLoughlin, R; Hansbro, NG; Liu, G; Shukla, SD; Mehta, M; Hansbro, PM; Chellappan, DK; Dua, K
2021-02Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities.Lee, L-Y; Hew, GSY; Meenu,; Shukla, SD; Satija, S; Khurana, N; Anand, K; Dureja, H; Singh, SK; Mishra, V; Singh, PK; Gulati, M; Prasher, P; Aljabali, AAA; Tambuwala, MM; Thangavelu, L; Panneerselvam, J; Gupta, G; Zacconi, FC; Shastri, M; Jha, NK; Xenaki, D; MacLoughlin, R; Oliver, BG; Chellappan, DK; Dua, K
-Targeting LIN28: a new hope in prostate cancer theranosticsShrivastava, G; Aljabali, AAA; Shahcheraghi, SH; Lotfi, M; Shastri, MD; Shukla, SD; Chellappan, DK; Jha, NK; Anand, K; Dureja, H; Pabari, RM; Mishra, V; Almutary, AG; Alnuqaydan, AM; Charbe, N; Prasher, P; Negi, P; Goyal, R; Dua, K; Gupta, G; Serrano-Aroca, Á; Bahar, B; Barh, D; Panda, PK; Takayama, K; Lundstorm, K; McCarron, P; Bakshi, H; Tambuwala, MM